I have a question about assembling mixed samples, where the organisms sampled are very similar. We usually sequence pure isolates but in a particular study ended up Illumina sequencing (paired ends) a sample that included a number of E. coli strains. These are all commensal E. coli but we know from separate work they have different phenotype and PFGE results. If each bacteria in the sample was a different organisms (e.g. E. coli, Salmonella, Acinetobacter) I know we could attempt to assemble the data and pull out separate genomes. But in this case, much of the genomes are identical or very similar. Yet other regions will include gene additions / deletions or genome re-arrangments. I was thinking that this would be analogous to assembling a plant or animal polyploid genome, where parts of the chromosome could be assembled to a haploid consensus but others would have multiple solutions, reflective of difference in chromosome copies. Can anyone suggest an assembly approach for our data or perhaps a polyploid assembler that may applied? Thanks!
Unconfigured Ad
Collapse
X
-
Genome assembly of mixed E. coli samples
-----
Andrew G. McArthur, Ph.D.
Associate Professor & Cisco Research Chair in Bioinformatics
Department of Biochemistry & Biomedical Sciences
McMaster University, Hamilton, Ontario, Canada
w. http://mcarthurbioinformatics.ca | e. [email protected] -
I don't know if the polyploid assemblers will work with your sample. Ignoring repetitive elements (which are difficult enough in haploids), polyploid genomes have (approximately) integer multiples of the haploid genome for variant representation. The data corresponding to one haploid genome, as well as the ploidy, can be estimated from kmer frequencies. For example, a tetraploid genome will typically have the tallest kmer peak at 4X the frequency of the first observable peak (the former represents the non-variant sequences, while the latter represents variants unique to one haploid genome), with peaks at 2X and 3X as well. Your sample has an unknown number of strains with non-integer representations, and you expect the majority of their genomes to be identical. Your predicted distribution of kmer frequencies would be one large peak corresponding to your depth of coverage, with no obvious peaks at lower coverage.
Perhaps the best approach would be to align the data to an E. coli reference with stringent parameters (e.g., minimal mismatches and gaps) to remove the bulk of the data, then try to assemble the unaligned reads with a metagenome assembler. Note that I have not attempted such an approach, so it may not work.
-
-
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
211 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
78 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment